United States · FDA National Drug Code directory
Nebivolol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-059_0ab335f1-2089-496b-b65f-02c697f6ee89
- Product NDC
- 71209-059
- Form
- TABLET
- Composition / generic term
- Nebivolol
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171229
- Source listing expiry
- 20261231
Source-listed ingredients
- NEBIVOLOL HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71209-059-01) · 71209-059-01
- 90 TABLET in 1 BOTTLE (71209-059-04) · 71209-059-04
- 100 TABLET in 1 BOTTLE (71209-059-05) · 71209-059-05
- 1000 TABLET in 1 BOTTLE (71209-059-11) · 71209-059-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →